134 related articles for article (PubMed ID: 17294523)
1. CD4+CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients.
Velthuis JH; Mol WM; Weimar W; Baan CC
Am J Transplant; 2006 Dec; 6(12):2955-64. PubMed ID: 17294523
[TBL] [Abstract][Full Text] [Related]
2. The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients.
Sewgobind VD; Kho MM; van der Laan LJ; Hendrikx TK; van Dam T; Tilanus HW; IJzermans JN; Weimar W; Baan CC
Nephrol Dial Transplant; 2009 May; 24(5):1635-44. PubMed ID: 19176684
[TBL] [Abstract][Full Text] [Related]
3. Kinetic analysis reveals potency of CD4+ CD25bright+ regulatory T-cells in kidney transplant patients.
Velthuis JH; Hesselink DA; Hendrikx TK; van der Mast BJ; Klepper M; de Greef GE; Baan CC; Weimar W
Transpl Immunol; 2007 Nov; 18(2):159-65. PubMed ID: 18005862
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of CD4+ CD25bright T cells in kidney transplant patients: improving suppression of donor-directed responses after transplantation.
Sewgobind VD; van der Laan LJ; Klepper M; Ijzermans JN; Tilanus HW; Weimar W; Baan CC
Clin Transplant; 2008; 22(5):579-86. PubMed ID: 18435785
[TBL] [Abstract][Full Text] [Related]
5. Functional CD25(bright+) alloresponsive T cells in fully immunosuppressed renal allograft recipients.
Baan CC; Velthuis JH; van Gurp EA; Mol WM; Klepper M; Ijzermans JN; Weimar W
Clin Transplant; 2007; 21(1):63-71. PubMed ID: 17302593
[TBL] [Abstract][Full Text] [Related]
6. Clinical rejection and persistent immune regulation in kidney transplant patients.
Hendrikx TK; Klepper M; Ijzermans J; Weimar W; Baan CC
Transpl Immunol; 2009 Jul; 21(3):129-35. PubMed ID: 19398001
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of CD4
McRae JL; Chia JS; Pommey SA; Dwyer KM
Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients.
Vallotton L; Hadaya K; Venetz JP; Buehler LH; Ciuffreda D; Nseir G; Codarri L; Villard J; Pantaleo G; Pascual M
Clin J Am Soc Nephrol; 2011 Aug; 6(8):2025-33. PubMed ID: 21757642
[TBL] [Abstract][Full Text] [Related]
9. Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors.
Mittal SK; Sharma RK; Gupta A; Naik S
Transplantation; 2009 Aug; 88(3):435-41. PubMed ID: 19667950
[TBL] [Abstract][Full Text] [Related]
10. A multiplex bead array analysis to monitor donor-specific cytokine responses after withdrawal of immunosuppression in HLA-identical living related kidney transplant patients.
Gerrits JH; van de Wetering J; van Beelen E; Claas FH; Weimar W; van Besouw NM
Transplant Proc; 2009 Jun; 41(5):1577-82. PubMed ID: 19545683
[TBL] [Abstract][Full Text] [Related]
11. Effect of mycophenolate mofetil regimen on peripheral blood lymphocyte subsets in kidney transplant recipients.
Bravo Soto JA; Esteban de la Rosa RJ; Luna del Castillo JD; Cerezo Morales S; García Olivares E; Osuna Ortega A; Asensio Peinado C
Transplant Proc; 2003 Jun; 35(4):1355-9. PubMed ID: 12826158
[TBL] [Abstract][Full Text] [Related]
12. Calcitriol started in the donor, expands the population of CD4+CD25+ T cells in renal transplant recipients.
Ardalan MR; Maljaei H; Shoja MM; Piri AR; Khosroshahi HT; Noshad H; Argani H
Transplant Proc; 2007 May; 39(4):951-3. PubMed ID: 17524860
[TBL] [Abstract][Full Text] [Related]
13. The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation.
Korczak-Kowalska G; Wierzbicki P; Bocian K; Klosowska D; Niemczyk M; Wyzgal J; Korecka A; Durlik M; Chmura A; Paczek L; Górski A
Transplant Proc; 2007 Nov; 39(9):2721-3. PubMed ID: 18021968
[TBL] [Abstract][Full Text] [Related]
14. Short-term anti-CD25 monoclonal antibody administration down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation.
Wang Z; Shi BY; Qian YY; Cai M; Wang Q
Clin Exp Immunol; 2009 Mar; 155(3):496-503. PubMed ID: 19141125
[TBL] [Abstract][Full Text] [Related]
15. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific suppression by induced CD4+CD25high regulatory T cells in kidney recipients.
Wang Z; Fu XY; Shi BY; Qian YY; Xiao L; Bai HW
Transplant Proc; 2009 Jun; 41(5):1574-6. PubMed ID: 19545682
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a negative conversion trial and subsequent living donor kidney transplant outcome in recipients with a positive lymphocyte crossmatch.
Huh KH; Kim SI; Joo DJ; Ju MK; Chang HK; Kim HJ; Kim YS; Kim MS
Nephron Clin Pract; 2009; 111(1):c49-54. PubMed ID: 19052470
[TBL] [Abstract][Full Text] [Related]
18. Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors.
Meloni F; Morosini M; Solari N; Bini F; Vitulo P; Arbustini E; Pellegrini C; Fietta AM
Int Immunopharmacol; 2006 Dec; 6(13-14):2002-10. PubMed ID: 17161354
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts.
Xia G; He J; Leventhal JR
Am J Transplant; 2008 Feb; 8(2):298-306. PubMed ID: 18190656
[TBL] [Abstract][Full Text] [Related]
20. Injection of donor-derived OX62+ splenic dendritic cells with anti-CD4 monoclonal antibody generates CD4+CD25+FOXP3+ regulatory T cells that prolong allograft skin survival indefinitely and abrogate production of donor-specific antibodies in a rat model.
Alawieh M; Rifle G; Bouchot O; Malapert G; Mousson C; Martin L
Transplant Proc; 2009 Oct; 41(8):3363-6. PubMed ID: 19857750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
